These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12903845)

  • 1. Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial.
    Wickerham DL
    Recent Results Cancer Res; 2003; 163():87-95; discussion 264-6. PubMed ID: 12903845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer prevention: results of the National Surgical Adjuvant Breast and Bowel Project (NSABP) breast cancer prevention trial (NSABP P-1: BCPT).
    Dunn BK; Ford LG
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S49-50. PubMed ID: 11056316
    [No Abstract]   [Full Text] [Related]  

  • 3. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
    Vogel VG
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Breast Cancer Prevention Trial: evaluating tamoxifen's efficacy in preventing breast cancer.
    McKeon VA
    J Obstet Gynecol Neonatal Nurs; 1997; 26(1):79-90. PubMed ID: 9017550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen--an update on current data and where it can now be used.
    Wickerham L
    Breast Cancer Res Treat; 2002 Oct; 75 Suppl 1():S7-12; discussion S33-5. PubMed ID: 12353826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors.
    Radmacher MD; Simon R
    J Natl Cancer Inst; 2000 Jan; 92(1):48-53. PubMed ID: 10620633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost effectiveness of tamoxifen in the prevention of breast cancer.
    Noe LL; Becker RV; Gradishar WJ; Gore M; Trotter JP
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S389-406. PubMed ID: 10538851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen's role in chemoprevention of breast cancer: an update.
    Nayfield SG
    J Cell Biochem Suppl; 1995; 22():42-50. PubMed ID: 8538209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the effect of tamoxifen chemoprevention on long-term mortality in white women at high risk of breast cancer.
    Maucort-Boulch D; Roy P
    Eur J Cancer Prev; 2006 Aug; 15(4):347-52. PubMed ID: 16835505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 2002 Oct; 94(19):1504. PubMed ID: 12359860
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.
    King MC; Wieand S; Hale K; Lee M; Walsh T; Owens K; Tait J; Ford L; Dunn BK; Costantino J; Wickerham L; Wolmark N; Fisher B;
    JAMA; 2001 Nov; 286(18):2251-6. PubMed ID: 11710890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hormone-related cancers: breast cancer.
    Dunn BK; Wickerham DL; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen and breast cancer--from palliation to prevention.
    Rich SE
    Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal approaches to breast cancer treatment and prevention: an overview.
    Vogel CL
    Semin Oncol; 1996 Aug; 23(4 Suppl 9):2-9. PubMed ID: 8824459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    Powles TJ
    J Natl Cancer Inst; 1999 Apr; 91(8):730. PubMed ID: 10218518
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient reluctance toward tamoxifen use for breast cancer primary prevention.
    Port ER; Montgomery LL; Heerdt AS; Borgen PI
    Ann Surg Oncol; 2001 Aug; 8(7):580-5. PubMed ID: 11508619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Narod S
    J Natl Cancer Inst; 1999 Jan; 91(2):188. PubMed ID: 9923863
    [No Abstract]   [Full Text] [Related]  

  • 20. Tamoxifen's impact on the management of breast cancer: patient perspectives.
    Reichman BS
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):55-8. PubMed ID: 9065929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.